Skip to main content

Table 1 Background characteristics of the patients (n = 64)

From: A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)

Gender, male (n) 52
Age, mean (± SD) 29.9 ± 7
Duration of heroin use (month) mean ± SDa 72.2 ± 94.2
Buprenorphine treatment (days) mean ± SD 63.3 ± 363
Subutex mean daily treatment dose (mg) ± SD 22.9 ± 5.4
  1. a59 patients reported history of heroin use